Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00900055 · ClinicalTrials.gov registry record

Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma

A clinical trial, sponsored by OHSU Knight Cancer Institute.

Completed
Registry status
213
Enrollment target

NCT00900055: Completed study, sponsored by OHSU Knight Cancer Institute.

NCT00900055 is a clinical trial that has completed, run by OHSU Knight Cancer Institute. The registered enrollment target is 213 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00900055 has completed, sponsored by OHSU Knight Cancer Institute.

COMPLETED
Registry status
213 participants
Enrollment target

Study Summary

RATIONALE: Analyzing tissue and blood samples from healthy volunteers or patients with Fanconi anemia, myelodysplasia, myeloproliferative disorders, or myeloma in the laboratory may help doctors learn more about the causes of blood cancers. PURPOSE: The purpose of this study is to analyze in the laboratory blood and bone marrow cells from healthy volunteers or patients with Fanconi anemia, myeloproliferative disorders, or myeloma.

Interventions

  • GENETIC microarray analysis
  • GENETIC protein expression analysis
  • GENETIC polymerase chain reaction
  • GENETIC reverse transcriptase-polymerase chain reaction
  • GENETIC polyacrylamide gel electrophoresis

Trial Details

FieldValue
Enrollment Target 213 participants
Start Date 1975-06
Est. Completion 2016-08-23
OHSU Knight Cancer Institute

211 total trials

What the finished NCT00900055 record still lists

NCT00900055 is an observational study that tracks outcomes without assigning an intervention. The registered 213 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 5 interventions - of which microarray analysis is the first listed.

NCT00900055 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00900055 about?

NCT00900055 is a clinical study titled "Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma". RATIONALE: Analyzing tissue and blood samples from healthy volunteers or patients with Fanconi anemia, myelodysplasia, myeloproliferative disorders, or myeloma in the laboratory may help doctors learn more about the causes of blood cancers. PURPOSE: The purpose of this study is to analyze in the la...

What is the current status of trial NCT00900055?

This trial is currently completed. The enrollment target is 213 participants. The study started on 1975-06. Estimated completion is 2016-08-23.

What interventions are being tested in trial NCT00900055?

The interventions under investigation include: microarray analysis (GENETIC), protein expression analysis (GENETIC), polymerase chain reaction (GENETIC), reverse transcriptase-polymerase chain reaction (GENETIC), polyacrylamide gel electrophoresis (GENETIC).

Who is sponsoring clinical trial NCT00900055?

This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06476886 · 213 participants · NA

    Intensive Crisis Intervention

  • NCT06544655 · 213 participants · Phase 1

    A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors

  • NCT07186816 · 213 participants · NA

    SUpport From PEeRs to Expand Access Study - Community

  • NCT04030507 · 214 participants · NA

    Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00900055, the US trial registry maintained by the National Library of Medicine. NCT00900055 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.